Clinical trial · Observational
Circulating Epigenetics in Pancreatic Surgery
Towards Precision Medicine in Pancreatic Surgery - an Integrative Approach Combining Deep Learning, Genetics and Epigenetics
NCT04947696CI-TRIAL-00052515unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The overall objective of the study is to assess DNA-methylation changes in circulating blood cells and cell free DNA in plasma from patients undergoing the Whipples procedure for pancreatic caner
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Pancreatic Neoplasms | Pancreatic Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Blood sampling | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- 1
- description
- Patients undergoing a Whipples procedure for pancreatic cancer
- interventionNames
- Diagnostic Test: Blood sampling
Primary outcomes (1)
- measure
- Changes in DNA-methylation patterns from the pre to postoperative setting
- timeFrame
- Up to 30 days postoperatively
Secondary outcomes (2)
- measure
- Occurence of a postoperative complication
- timeFrame
- 30 days postoperatively
- measure
- Relapse of pancreatic cancer
- timeFrame
- 2 years from time of operation
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients with pancreatic cancer scheduled for the Whipples procedure Exclusion Criteria: * Under 18 years of age * Pregnancy * Unable to provide informed consent.
References
Publications (0)
Data not yet available
No reference posted for this study.